The Original Investigation titled “Association of Low-Dose Whole-Body Computed Tomography With Missed Injury Diagnoses and Radiation Exposure in Patients With Blunt Multiple Trauma,”1 published online January 15, 2020, was corrected to add missing affiliations for Drs Mutze and Ekkernkamp and to add a missing data point in eTable 4 in the Supplement. This article was corrected online.

The Research Letter titled “Evaluation of Triple-Negative Breast Cancer Early Detection Via Mammography Screening and Outcomes in African American and White American Patients,”1 published online February 19, 2020, included an error in the Methods section and another in the Results section. The Methods section notes the date of study termination as April 30, 2018. In fact, it was September 14, 2018

Gastrointestinal stromal tumors (GISTs) are malignant tumors arising from interstitial cells of cajal that can be located in any part of the digestive system.1 Their most common sites are the stomach and small intestine.2 Surgery either upfront or after preoperative treatment with tyrosine kinase inhibitors (TKIs) is still the most important treatment modality in GIST.2 In this issue of JAMA Surgery

Suresh Agarwal Hasan B. Alam Karim Alavi

In Reply We thank Tian et al for their letter and interest in our article.1 We agree with the authors that ex vivo lung perfusion (EVLP), regardless of platform, has consistently been shown to provide short-term outcomes similar to those of conventional lung transplantation.2,3 In our article, we focused on the longer-term outcomes, and these too were similar between EVLP-treated and non-EVLP donor

To the Editor We read with great interest the article by Divithotawela et al,1 which demonstrated the posttransplant long-term outcomes were similar between ex vivo lung perfusion (EVLP)–treated lung transplant (LTx) and standard LTx, although the quality of donor lungs was worse with EVLP-treated LTx. To our knowledge, this study is the largest study of EVLP and includes 230 EVLP cases. We congratulate

Mission Statement: To promote the art and science of surgery by publishing relevant peer-reviewed research to assist the surgeon in optimizing patient care. JAMA Surgery will also serve as a forum for the discussion of issues pertinent to surgery, such as the education and training of the surgical workforce, quality improvement, and the ethics and economics of health care delivery.

In the Original Investigation titled “Effect of Multimodal Prehabilitation vs Postoperative Rehabilitation on 30-Day Postoperative Complications for Frail Patients Undergoing Resection of Colorectal Cancer: A Randomized Clinical Trial,”1 published online January 22, 2020, a correction was made to fix the affiliation for Drs Liberman, Stein, Charlebois, and Fiore, which had been given as the Department

In the Original Investigation titled “Comparison of Decompressing Stoma vs Stent as a Bridge to Surgery for Left-Sided Obstructive Colon Cancer,”1 published online January 8, 2020, the third sentence in the Abstract Results was changed from “Patients undergoing SEMS had more primary anastomoses” to “Patients undergoing DS had more primary anastomoses.” This article has been corrected online.

In the Surgical Innovations article, “Primary Fascial Closure During Minimally Invasive Ventral Hernia Repair,”1 published online December 26, 2019, an error appeared in the text. The 95% CI of a relative risk for a study by Ahonens et al was misreported as 2.8 to 13.3. The correct 95% CI is 0.08 to 0.36. The article has been corrected online.

In Reply We appreciate the interest in our article and thank JAMA Surgery for the opportunity to reply to the letters to the editor.1 Shi et al advised that combining patients without postoperative pancreatic fistula (POPF) and with biochemical leakage may have biased the analysis regarding long-term survival in patients receiving neoadjuvant therapy (NAT). While biochemical leakage may reflect a more

To the Editor We read with interest the study of Hank et al,1 which proposes that there is a decreased risk of developing clinically relevant pancreatic fistula (CR-POPF) when neoadjuvant chemotherapy (NAT) therapy is applied for pancreatic adenocarcinoma. They suggest induction of fibrosis of the pancreatic gland as a proposed mechanism. While the data appear intriguing, there are some methodologic

To the Editor We have read with great interest the article by Hank et al.1 The authors indicated that neoadjuvant therapy (NAT) could reduce the rate of clinically relevant postoperative pancreatic fistula (CR-POPF). In addition, they demonstrated that CR-POPF is associated with a significant reduction in long-term survival for patients with pancreatic cancer with NAT.

To the Editor We have read with great interest the article by Petro and Rosen regarding the elegantly titled “Bouffant Scandal.”1 In the era of evidence-based medicine, the heated debate about which surgical cap should adorn the heads of surgeons is, rather surprisingly, laden with nonscientific, sometimes petty and disingenuous arguments. The purpose of generating clinical practice guidelines is the

In Reply We greatly appreciate the consideration and comments from the group at McGill University regarding our study,1 as well as their own published contribution to this topic2 in which they have shown very little value of routine esophagram to the clinical management of anastomotic leaks after esophagectomy. We are in agreement that most routine esophagrams are negative studies and that the low

To the Editor It is with great interest that we reviewed the study by Haisley et al1 relating to the importance of early detection of anastomotic leak (AL). During the study period, 227 patients underwent esophagectomy, of whom 22 experienced AL. Of these, 32% were identified by routine contrast esophagram (CE), and the remaining 68% were identified clinically after normal CE. The authors report a

In Reply We thank Van der Vliet et al for their insightful comments. Regarding data in US trauma systems, there is room to learn from the Dutch example and others who have taken a more inclusive approach to trauma registries. We also agree with their assertion that trauma registries should include all patients admitted for trauma because we have previously shown the utility of this broader inclusion

To the Editor Trauma registries have been established in many countries to collect data for quality assessment, quality improvement, and research purposes. Information pertaining to patients and health systems based on trauma registry data is subject to trauma registry inclusion and exclusion criteria. Generalizability of outcome data is limited when inclusion criteria are narrow. Application of strict

While we love the allure of large numbers and the confidence instilled by small P values, we should remember that within the variables we count, there is variation and nuance that can be critically important to our understanding of how we provide surgical care and ways to improve it.1 Unlike most quantitative methods that provide a 50 000-foot view, qualitative analysis starts from the ground and moves

Constraints on US health care resources provide incentives to maximize outcomes among surgical patients while limiting the costs of providing care. Cost-effectiveness analysis (CEA) is a statistical method that allows researchers to simultaneously compare the trade-offs between costs and health effects of different surgical interventions. The resultant metrics can help inform decisions about adopting

Concern about long-term donor outcomes has existed since the first kidney transplant was performed. Studies1,2 comparing long-term outcomes among living donors with those of the general population have found no differences; however, 2 recent studies comparing donors with healthy selected control participants have found that living kidney donors have a small increased risk for end-stage renal disease

In an attempt to minimize missed injury rates, potentially decrease mortality, and enhance rapid patient disposition, standard-dose whole-body computed tomographic (WBCT) imaging has become ubiquitous at trauma centers for the hemodynamically stable patient admitted with trauma.1,2 The radiation dose from WBCT ranges from 10 to 20 mGy, which results in an approximately 0.08% estimated lifetime cancer

The uptake of bariatric surgery remains low in the United States, with fewer than 1% of eligible patients undergoing this life-saving treatment.1 In addition to the obesity bias that delays referral for surgery, some continue to fear the short- and long-term risks of surgery. To date, most long-term outcome data have focused on Roux-en-Y gastric bypass (RYGB),2 but sleeve gastrectomy (SG) is now the

Roughly translated from the Danish Nobel Prize physicist Niels Bohr, “it is difficult to make predictions, especially about the future.”1 Of course, his statement was made in the context of quantum physics. As clinicians in the operating room and intensive care units where we are overwhelmed with continuous physiologic data, the amount of data may sometimes overwhelm our capacity to analyze and apply

In Reply We first thank the authors of these letters for taking the time to comment on our work1 and for their shared interest in improving diversity, equity, and inclusivity in surgery. The primary goals of publishing our data were to identify racial, ethnic, and sex differences in board passage rates as a problem and to stimulate conversation around how to take action to improve metrics that appear

To the Editor As an organization devoted to advancing women in cardiothoracic surgery, we read with great interest the study by Yeo et al1 identifying demographic factors associated with pass rates on the American Board of Surgery examinations, and we congratulate the authors. On behalf of the Women in Thoracic Surgery, we would like to echo the authors’ call to action, share our understanding of the

To the Editor Yeo et al1 evaluated factors associated with American Board of Surgery (ABS) examination pass rates in a cohort of categorical surgical residents from the internship (2007) to eligibility/certification. They found that first-time ABS pass rate was associated with nonmodifiable factors, such as nonwhite race/ethnicity, sex (women), and having children.1 Additionally, Hispanic residents

In surgery, unprofessional behaviors have been shown to affect team and individual performance and result in greater risk for surgical complications and malpractice claims.1-4 Until now, there have been limited data to support early-career identification of surgeons at risk of unprofessional practices, which could guide potential prevention efforts. In this issue of JAMA Surgery, Kopp et al5 assessed

The use of the robotic platform for primary inguinal hernia repair has been a controversial topic. In this issue of JAMA Surgery, the multicenter, pilot clinical trial by Prabhu et al1 is, to our knowledge, the first of its kind to compare outcomes of laparoscopic and robotic transabdominal preperitoneal inguinal hernia repair. The study showed no differences in postoperative outcomes between the 2

In Reply We thank Hussain, who highlighted important issues regarding the article we published.1 Our retrospective study showed that patients with primary hyperparathyroidism and hypertension who underwent parathyroidectomy had decreased antihypertensive medication requirements and lower mean arterial pressure (MAP) when compared with those without surgery.

To the Editor Graff-Baker et al1 are to be congratulated for their investigation regarding whether parathyroidectomy reverses hypertension in patients with primary hyperparathyroidism (PHPT) compared with nonsurgical patients by assessing changes in mean arterial pressure (MAP) and antihypertensive medication use in their retrospective cohort study. Hypercalcemia and elevated parathyroid hormone levels